Human medicines European public assessment report (EPAR): Ondibta, insulin glargine, Date of authorisation: 09/01/2026, Revision: 3, Status: Authorised
الصحة واللياقة البدنية
Human medicines European public assessment report (EPAR): Ondibta, insulin glargine, Date of authorisation: 09/01/2026, Revision: 3, Status: Authorised
Human medicines European public assessment report (EPAR): Ondibta, insulin glargine, Date of authorisation: 09/01/2026, Revision: 3, Status: Authorised
AAdmin
٢١ أغسطس ٢٠٢٦
1 دقيقة قراءة
